Which alpha-adrenergic blocking agent is used as a reversal for medetomidine?

Which alpha-adrenergic blocking agent is used as a reversal for medetomidine?

• A. Yohimbine
• B. Tolazoline
• C. Naloxone
• D. Atipamezole

Answer: (D)

Reversing the effects of an alpha-2 adrenergic agonist relies on using an antagonist that specifically blocks those same receptors. Medetomidine is an alpha-2 agonist used for sedation and analgesia; it works by activating alpha-2 receptors in the brain and spinal cord to reduce norepinephrine release, producing calm, analgesia, and often bradycardia or hypotension. To undo these effects, you need an antagonist with a high affinity for alpha-2 receptors so it can outcompete the agonist and quickly restore sympathetic activity.

Atipamezole is the drug that best fits this role. It is a selective alpha-2 adrenergic antagonist with strong affinity for these receptors, giving a rapid and predictable reversal of both sedation and analgesia produced by medetomidine. While other agents that blocks alpha-2 receptors exist, atipamezole offers faster, more reliable reversal with a favorable safety profile in typical veterinary use. Naloxone, in contrast, reverses opioid effects and does not address alpha-adrenergic action, so it won’t reverse medetomidine.